Seaport Therapeutics, Inc. (SPTX)
Nasdaq: SPTX · Pharmaceutical Preparations · filing with the SEC since 2024
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal quarter | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|
| Period ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 |
| Report filed | Nov 2, 2026 | Aug 3, 2026 | Jun 8, 2026 |
| Research and development | 23,891 | 24,619 | 21,431 |
| General and administrative | 6,454 | 41,189 | 6,112 |
| Total operating expenses | 30,345 | 65,808 | 27,543 |
| Operating income | -30,345 | -65,808 | -27,543 |
| Interest income (expense), net | 3,900 | 3,257 | 2,133 |
| Other income (expense), net | 13 | · | · |
| Total non-operating income (expense) | 4,078 | 3,459 | 2,654 |
| Income before income taxes | -26,267 | -62,349 | -24,889 |
| Income tax expense | 127 | 251 | 519 |
| Net income including non-controlling interests | · | · | -25,408 |
| Net income | -26,394 | -62,600 | -25,408 |
| Earnings per share, basic | -0.49 | -1.78 | -10.34 |
| Earnings per share, diluted | -0.49 | -1.78 | -10.34 |
| Weighted average shares, basic | 53,530,550 | 35,236,214 | 2,456,766 |
| Weighted average shares, diluted | 53,530,550 | 35,236,214 | 2,456,766 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Each quarter is three months. A fourth quarter prints only where the company tagged its three months on their own; the whole year is in the annual view.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding